脑部放疗，上午比下午敏感许多！: s: a/ c% q2 B3 _% r1 ^$ ?& i7 d
3 F; e, z" G/ x ~$ l" c9 S. q
3 a1 g( z7 o: Z4 nCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
3 I% t8 B6 A$ {, D6 D. wGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
4 _" M2 y; B' G1 J! @& WRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
# _3 ^/ i6 J& N5 d. Q9 BSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
* t- T) d7 Y& G; s8 |2 T- D9 O3 [1 ?- B0 f
Abstract/ H9 [% O. Q$ ~9 D# S6 m
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time., o5 |- z4 Y2 p! n6 ?5 }
, {4 G( t$ P0 u" H1 H6 T: Y5 B
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
f+ B+ N- {: ], H& }5 T( ?9 j+ T3 }" c, L ]' K' L
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).0 Q; g7 ]$ S3 O6 `6 Z7 v& t7 D
5 \% L+ A. l0 W1 A
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
4 D# _& T2 ]" H. o* q
7 {! e& ]9 C- V |
显身卡
